. | Dietary treatment . | . | . | ||
---|---|---|---|---|---|
Amino acid . | Free AA . | Dipeptide . | Casein(-) . | ||
Gln* | 949±43b | 1211±150a | 1363±86a | ||
Glu* | 1216±101 | 1746±493 | 1905±24 | ||
Ser* | 875±262 | 1530±529 | 1414±44 | ||
Tyr* | 96±22b | 254±135a,b | 350±63a | ||
Val* | 211±31b | 173±29b | 510±94a | ||
Leu* | 156±20b | 204±91b | 441±96a | ||
Phe* | 31±2 | 69±28 | 57±8 | ||
Trp* | 33±6b | 48±11a,b | 56±4a | ||
Lys* | 426±53b | 1328±579a | 1945±138a | ||
Sum DAA† | 35.6±1.0a | 36.0±2.3a | 27.0±1.8b | ||
Sum IDAA† | 4.1±0.3b | 3.7±0.7b | 11.1±1.0a | ||
Sum FAA† | 39.7±1.1 | 39.7±3.0 | 38.1±2.6 | ||
Orn/Pro‡ | 0.01±0.01b | 0.12±0.02a | 0.01±0.01b | ||
Hyp/Pro‡ | 0.09±0.09b | 1.14±0.15a | 0.86±0.22a |
. | Dietary treatment . | . | . | ||
---|---|---|---|---|---|
Amino acid . | Free AA . | Dipeptide . | Casein(-) . | ||
Gln* | 949±43b | 1211±150a | 1363±86a | ||
Glu* | 1216±101 | 1746±493 | 1905±24 | ||
Ser* | 875±262 | 1530±529 | 1414±44 | ||
Tyr* | 96±22b | 254±135a,b | 350±63a | ||
Val* | 211±31b | 173±29b | 510±94a | ||
Leu* | 156±20b | 204±91b | 441±96a | ||
Phe* | 31±2 | 69±28 | 57±8 | ||
Trp* | 33±6b | 48±11a,b | 56±4a | ||
Lys* | 426±53b | 1328±579a | 1945±138a | ||
Sum DAA† | 35.6±1.0a | 36.0±2.3a | 27.0±1.8b | ||
Sum IDAA† | 4.1±0.3b | 3.7±0.7b | 11.1±1.0a | ||
Sum FAA† | 39.7±1.1 | 39.7±3.0 | 38.1±2.6 | ||
Orn/Pro‡ | 0.01±0.01b | 0.12±0.02a | 0.01±0.01b | ||
Hyp/Pro‡ | 0.09±0.09b | 1.14±0.15a | 0.86±0.22a |
Data are given as tank means ± s.d. in μmol kg-1 wet muscle mass (N=3).
Sums of DAA (dispensable amino acids), IDAA (indispensable amino acids) and total FAA (free amino acids) (mmol kg-1 wet mass) represent the sum of FAA given here and in Fig. 2.
Orn/Pro and Hyp/Pro data were calculated from values given in Fig. 2.
Superscript letters represent significant effects of dietary treatment;data within an experiment not sharing a superscript letter are significantly different at P<0.05.